Skip to content
value.today

Goldfinch Bio, Inc.

Total raised
$70 M
1 round on record
Latest round
$70 M
Jun 2020
First round on record
Jun 2020
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Goldfinch Bio, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2020$70 MNo. 1$50 to $250 million

Goldfinch Bio, Inc.: Raise no. 1, Jun 2020

Investors in this round

26 investors had bought by the notice of Jul 14, 2020: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Goldfinch Bio, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$70 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Anthony Johnson · Executive Officer, Director
  • Curtis Demick · Executive Officer
  • Frank Czerwiec · Executive Officer
  • Jean-Christophe Harmange · Executive Officer
  • Kyle Kuvalanka · Executive Officer
  • Lori Rudolph-Owen · Executive Officer
  • Abbie Celniker · Director
  • Frank Maddux · Director
  • Joy Ghosh · Director
  • Louis Brenner · Director
  • Neil Exter · Director
  • Wen Chen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Anthony Johnson, Presdient and ceo. Source: SEC Form D, newest notice filed Jul 14, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Goldfinch Bio, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2020).

    SEC Form D · Jul 2020

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Jul 2020

That is all the official record says: Goldfinch Bio, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: its website did not answer.

Investors#

3 named in official filings. Open an investor to see everything it has backed.

Investors in Goldfinch Bio, Inc.
InvestorKindAmountRoundRoleSource
BlackRock Health Sciences Term TrustFund or asset manager$1 Mheldnot statedHolds shares (fund report, Jun 2026)SEC Form N-PORT
BlackRock Health Sciences Opportunities PortfolioFund or asset manager$1 Mheldnot statedHolds shares (fund report, May 2026)SEC Form N-PORT
BlackRock Health Sciences TrustFund or asset manager$0 Mheldnot statedHolds shares (fund report, Jun 2026)SEC Form N-PORT

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 26 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Goldfinch Bio, Inc.
NameRoleNamed in
Anthony JohnsonExecutive officerJul 2020
Curtis DemickExecutive officerJul 2020
Frank CzerwiecExecutive officerJul 2020
Jean-Christophe HarmangeExecutive officerJul 2020
Kyle KuvalankaExecutive officerJul 2020
Lori Rudolph-OwenExecutive officerJul 2020
Abbie CelnikerDirectorJul 2020
Anthony JohnsonDirectorJul 2020
Frank MadduxDirectorJul 2020
Joy GhoshDirectorJul 2020
Louis BrennerDirectorJul 2020
Neil ExterDirectorJul 2020
Wen ChenDirectorJul 2020

About

Organization.